Sera Medicines, LLC
Biotechnology Research
A biologics-focused accelerator advancing next-generation therapies with the potential to be transformative for patients
About us
Sera Medicines is a biologics-focused accelerator advancing next-generation protein therapeutics with the potential to be transformative for patients. Our team consists of experts in biology, chemistry, antibody engineering, drug discovery, manufacturing, clinical development, and other critical functions to create and launch exceptional companies around next-generation therapies. Once a program incubated at Sera achieves key value inflection, we enable rapid progression toward and beyond the clinic via the formation and financing of spinouts, such as Tenet Medicines and Navigator Medicines.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Partnership
- Founded
- 2023
- Specialties
- Protein Engineering, Antibody Discovery, Biologics R&D, BD&L, Company Formation, and Fundraising